Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Argus Health
Dow
Fuji
QuintilesIMS
Federal Trade Commission
Healthtrust
Johnson and Johnson
Medtronic

Generated: December 19, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BENAZEPRIL HYDROCHLORIDE; HYDROCHLOROTHIAZIDE

« Back to Dashboard

Clinical Trials for Benazepril Hydrochloride; Hydrochlorothiazide

Trial ID Title Status Sponsor Phase Summary
NCT00170950 Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension Terminated Novartis Phase 3 A comparison study of two combination drugs, amlodipine/benazepril and benazepril/HCTZ to evaluate the effectiveness of the combination on reducing heart disease and death in a high risk hypertensive population.
NCT00367094 Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension Completed Novartis Phase 3 This study will evaluate efficacy and safety data for benazepril/hydrochlorothiazide in adult Chinese patients with mild to moderate essential hypertension. Patients whose blood pressure is not adequately controlled with benazepril monotherapy during a 4 week run-in period will be randomly allocated to double blind treatment over 8 weeks with either a combination of benazepril/hydrochlorothiazide per day or continuation of benazepril per day.
NCT00649038 Fed Study of Benazepril HCl and Hydrochlorothiazide Tablets 20 mg/25 mg to Lotensin HCT® Tablets 20 mg/25 mg Completed Mylan Pharmaceuticals Phase 1 The objective of this study was to investigate the bioequivalence of Mylan benazepril HCl and hydrochlorothiazide 20 mg/25 mg to Novartis Lotensin HCT® 20 mg/25 mg combination tablets following a single, oral 40 mg/50 mg (2 x 20 mg/25 mg) dose administration under fed conditions.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Benazepril Hydrochloride; Hydrochlorothiazide

Condition Name

Condition Name for Benazepril Hydrochloride; Hydrochlorothiazide
Intervention Trials
Healthy 4
Hypertension 3
Albuminuria 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Benazepril Hydrochloride; Hydrochlorothiazide
Intervention Trials
Hypertension 3
Albuminuria 1
Diabetes Mellitus, Type 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Benazepril Hydrochloride; Hydrochlorothiazide

Trials by Country

Trials by Country for Benazepril Hydrochloride; Hydrochlorothiazide
Location Trials
United States 5
Denmark 1
Sweden 1
Taiwan 1
Norway 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Benazepril Hydrochloride; Hydrochlorothiazide
Location Trials
North Carolina 2
North Dakota 2
New Jersey 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Benazepril Hydrochloride; Hydrochlorothiazide

Clinical Trial Phase

Clinical Trial Phase for Benazepril Hydrochloride; Hydrochlorothiazide
Clinical Trial Phase Trials
Phase 4 1
Phase 3 2
Phase 1 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Benazepril Hydrochloride; Hydrochlorothiazide
Clinical Trial Phase Trials
Completed 6
Terminated 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Benazepril Hydrochloride; Hydrochlorothiazide

Sponsor Name

Sponsor Name for Benazepril Hydrochloride; Hydrochlorothiazide
Sponsor Trials
Mylan Pharmaceuticals 2
Novartis 2
Ranbaxy Laboratories Limited 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Benazepril Hydrochloride; Hydrochlorothiazide
Sponsor Trials
Industry 7
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
UBS
Daiichi Sankyo
McKinsey
Chinese Patent Office
Covington
Fuji
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.